FDA
approval
· 2021-05-26
FDA Approved: DUTASTERIDE — Supplemental Application (Epic Pharma, LLC)
Summary
FDA approved Epic Pharma's supplemental application to bring a generic dutasteride product to market for the treatment of benign prostatic hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DUTASTERIDE (DUTASTERIDE)